Reports: Legislative

January 22, 2024
The Louisiana Sickle Cell Commission (LSCC) is a statutorily established advisory body that works to improve the delivery of sickle cell services in Louisiana. The LSCC comprises 17 members representing clinical care systems, supportive services, advocates, and individuals with lived experience.
January 22, 2024
The Louisiana Rare Disease Advisory Council (LA RDAC) is a statutorily mandated advisory group that is charged with serving in a resource capacity to any public and private agency located in this state that provides services for a person who has been diagnosed with a rare disease. The LA RDAC is administered through the Louisiana Department of Health (LDH or the Department) Office of Public Health (OPH) Bureau of Family Health (BFH), which provides staff support and policy expertise to assist the group with carrying out its charge.
January 22, 2024
The Louisiana Department of Health, Office of Public Health’s Bureau of Family Health (BFH), coordinates the Child Death Review (CDR) Program. As mandated by Louisiana Revised Statute 40:2019 , CDRs are conducted for unexpected deaths of children under 15 years of age. State and local panels meet to review child deaths, identify risk factors, and provide recommendations for preventive action. The Louisiana CDR Program is primarily funded through the Federal Title V Maternal and Child Health Block Grant and the Centers for Disease Control and Prevention’s (CDC) Sudden Unexpected Infant Death (SUID) Case Registry grant.
January 22, 2024
The Louisiana Birth Defects Monitoring Network (LBDMN) within the Bureau of Family Health (BFH), Office of Public Health (OPH), Louisiana Department of Health (LDH) is responsible for surveillance of birth defects in Louisiana's children. Mandated in 2004, it was the intent of the legislature to “establish a system to collect, analyze, and disseminate data regarding birth defects in the state and to provide information to families of children born with birth defects regarding services available in their community and the development of appropriate prevention programs."
January 04, 2024
This report is submitted according to House Resolution 269 of the 2023 Regular Legislative Session, which requests that the Louisiana Department of Health (LDH) study opportunities to increase the availability of prescription nonopioid medications in treating pain.
January 03, 2024
Annual reports from Louisiana's Medicaid program (Bureau of Health Services Financing).
January 03, 2024
In response to ACT 482 of the 2018 Regular Legislative Session the Louisiana Department of Health (LDH) is required to submit the Medicaid Managed Care Quarterly Transparency report.
December 27, 2023
The annual Synar Report describes the progress Louisiana and other states have made in enforcing youth tobacco access laws and future plans to reduce youth tobacco access rates as required by the federal Public Health Service Act [42 U.S.C. 300x–26]. The law requires all states to have in effect a law making it unlawful for any manufacturer, retailer, or distributor of tobacco products to sell or distribute any such product to any individual under the age of 18, and to conduct random, unannounced inspections to ensure compliance with the law. States are required to report this information annually to the federal Substance Abuse and Mental Health Services Administration’s (SAMHSA) Center for Substance Abuse Prevention (CSAP).
December 13, 2023
This report is submitted to the House Committee on Health and Welfare and the David R. Poynter Legislative Research Library in response to House Resolution (HR) 200 of the 2023 Regular Legislative Session, by Representative Christopher Turner, which the Speaker of the House enrolled and signed on June 4, 2023.
December 13, 2023
The Department of Health (LDH) submits the attached report in response to Act 311 of the 2013 Regular Session. Act 311 requests LDH to report to the House and Senate Committees on Health and Welfare the incidence and causes of all re-hospitalizations of infants born premature at less than thirty-seven weeks gestational age and who are within the first six months of life.
Accessibility